Adalimumab treatment of resistant chondrocalcinosis
Authors:
- 10 October 2024
- journal article
- case report
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 20 (8) , 452-453
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Calcium pyrophosphate deposition (CPPD) disease – Treatment optionsBest Practice & Research Clinical Rheumatology, 2021
- Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot studyAnnals of the Rheumatic Diseases, 2020
- Cartilage diseasesMatrix Biology, 2018
- Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 casesClinical Rheumatology, 2018
- Interleukin-6 pathway blockade as an option for managing refractory cases of crystal arthritis: Two cases reportJoint Bone Spine, 2018
- Calcium Pyrophosphate Deposition DiseaseNew England Journal of Medicine, 2016
- The Emerging Role of Biotechnological Drugs in the Treatment of GoutBioMed Research International, 2014
- European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosisAnnals of the Rheumatic Diseases, 2011